Christopher Gibson, Ph.D.

Christopher Gibson, Ph.D., is the co-founder and Chairman of the Board of Directors of Recursion, a clinical-stage biotechnology company that has developed one of the industry’s most advanced AI-driven drug discovery platforms. Under Dr. Gibson’s leadership, Recursion integrated large-scale biological data generation with machine learning and automation, building a vertically integrated technology stack spanning high-dimensional biology and artificial intelligence. He led the company from inception through substantial capital formation, strategic partnerships, and a successful public listing, establishing Recursion as a leader at the intersection of computation and biology. Dr. Gibson’s deep expertise in leveraging data-intensive approaches to accelerate biological discovery will support PacBio’s vision for integrating sequencing, computation, and data-driven insights.